Qualigen Therapeutics, Inc. financial data

Symbol
QLGN on Nasdaq
Location
2042 Corte Del Nogal, Carlsbad, California, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 358 % +1178%
Quick Ratio 20.2 % -21%
Debt-to-equity 938 % +1361%
Return On Equity -73 % -128%
Return On Assets -52.6 % +90.2%
Operating Margin -196 % +49.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.16M shares +601%
Common Stock, Shares, Outstanding 3.06M shares +458%
Entity Public Float 1.65M USD -63.9%
Common Stock, Value, Issued 67.7K USD +3.71%
Weighted Average Number of Shares Outstanding, Basic 621K shares +60%
Weighted Average Number of Shares Outstanding, Diluted 621K shares +60%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.07M USD +26.7%
Research and Development Expense 112K USD -95.6%
General and Administrative Expense 6.8M USD +63.7%
Operating Income (Loss) -7.17M USD -6.92%
Nonoperating Income (Expense) -48.5K USD +95.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.22M USD +7.27%
Income Tax Expense (Benefit) 4.58K USD -98%
Net Income (Loss) Attributable to Parent -7.23M USD +8%
Earnings Per Share, Basic 7 USD/shares +0.43%
Earnings Per Share, Diluted 7 USD/shares +0.43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.8M USD +9890%
Accounts Receivable, after Allowance for Credit Loss, Current 539K USD 0%
Inventory, Net 1.56M USD +19.3%
Other Assets, Current 14.1K USD
Assets, Current 43.5M USD +1779%
Property, Plant and Equipment, Net 499K USD +51.3%
Operating Lease, Right-of-Use Asset 1.31M USD -15%
Intangible Assets, Net (Excluding Goodwill) 5.83M USD -0.43%
Goodwill 626K USD -87.2%
Other Assets, Noncurrent 2K USD
Assets 43.5M USD +1779%
Accounts Payable, Current 1.28M USD -21.7%
Accrued Liabilities, Current 41.9K USD -92.7%
Liabilities, Current 4.92M USD +10.5%
Deferred Income Tax Liabilities, Net 150K USD
Operating Lease, Liability, Noncurrent 1.17M USD -18%
Liabilities 4.14M USD -59.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 132K USD +101%
Retained Earnings (Accumulated Deficit) -129M USD -5.91%
Stockholders' Equity Attributable to Parent 38.5M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 38.5M USD
Liabilities and Equity 43.5M USD +1779%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.59M USD -103%
Net Cash Provided by (Used in) Financing Activities 750K USD +57.9%
Net Cash Provided by (Used in) Investing Activities -305K USD
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 3.06M shares +458%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.6M USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38.8M USD +9890%
Deferred Tax Assets, Valuation Allowance 17.8M USD -61%
Deferred Tax Assets, Gross 17.8M USD -61%
Operating Lease, Liability 1.43M USD -11.1%
Depreciation 84K USD -4.55%
Payments to Acquire Property, Plant, and Equipment 198K USD +299%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.26M USD +53.1%
Lessee, Operating Lease, Liability, to be Paid 1.74M USD -21%
Property, Plant and Equipment, Gross 5.25M USD +40.3%
Operating Lease, Liability, Current 257K USD +44.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 391K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 379K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 310K USD -47.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 402K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 8.64M USD -73.5%
Preferred Stock, Shares Issued 45K shares
Preferred Stock, Shares Authorized 15M shares
Unrecognized Tax Benefits 279K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 379K USD -5.8%
Additional Paid in Capital 132M USD +9.84%
Preferred Stock, Shares Outstanding 45K shares
Depreciation, Depletion and Amortization 58.7K USD +97.2%
Share-based Payment Arrangement, Expense 128K USD -88.3%
Interest Expense 74K USD +8.82%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares